ArticleBMC gastroenterology2025

Comprehensive analysis of glycometabolism-related genes reveals PLOD2 as a prognostic biomarker and therapeutic target in gastric cancer.

Wanchun Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.